Signaling mechanism of growth hormone-releasing hormone receptor

Barabutis, 2010, Growth hormone-releasing hormone: Extrapituitary effects in physiology and pathology, Cell Cycle, 9, 4110, 10.4161/cc.9.20.13787 Cai, 2014, Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities, Peptides, 52, 104, 10.1016/j.peptides.2013.12.010 Catanuto, 2015, Expression of receptors for pituitary-type growth hormone-releasing hormone (pGHRH-R) in human papillary thyroid cancer cells: Effects of GHRH antagonists on matrix metalloproteinase-2, Hormones and Cancer, 6, 100, 10.1007/s12672-015-0217-2 Chatzistamou, 2008, Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas, Regulatory Peptides, 147, 33, 10.1016/j.regpep.2007.12.008 Chu, 2016, Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells, Proceedings of the National Academy of Sciences of the United States of America, 113, 14396, 10.1073/pnas.1617427113 Cong, 2021, Constitutive signal bias mediated by the human GHRHR splice variant 1, Proceedings of the National Academy of Sciences of the United States of America, 118 Cui, 2016, Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways, Oncotarget, 7, 52661, 10.18632/oncotarget.11024 DeAlmeida, 1998, Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins, Molecular Endocrinology, 12, 750, 10.1210/mend.12.5.0102 Dubreuil, 2001, The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues, Growth Hormone & IGF Research, 11, 173, 10.1054/ghir.2001.0150 Farkas, 2012, Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer, Journal of Cancer Research and Clinical Oncology, 138, 387, 10.1007/s00432-011-1110-1 Fridlyand, 2016, Growth hormone-releasing hormone in diabetes, Frontiers in Endocrinology (Lausanne), 7, 129 Gaylinn, 1999, The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH, Endocrinology, 140, 5066, 10.1210/endo.140.11.7092 Gaylinn, 1993, Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone, Molecular Endocrinology, 7, 77 Gaylinn, 1994, Photoaffinity cross-linking to the pituitary receptor for growth hormone-releasing factor, Endocrinology, 135, 950, 10.1210/endo.135.3.8070391 Gesmundo, 2017, Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure, Proceedings of the National Academy of Sciences of the United States of America, 114, 12033, 10.1073/pnas.1712612114 Gesmundo, 2022, Antagonist of growth hormone-releasing hormone potentiates the antitumor effect of pemetrexed and cisplatin in pleural mesothelioma, International Journal of Molecular Sciences, 23, 10.3390/ijms231911248 Halmos, 2000, Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone, Proceedings of the National Academy of Sciences of the United States of America, 97, 10555, 10.1073/pnas.180313097 Havt, 2005, The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues, Proceedings of the National Academy of Sciences of the United States of America, 102, 17424, 10.1073/pnas.0506844102 Hohla, 2008, Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the esophagus and colon, International Journal of Oncology, 33, 137 Jaszberenyi, 2012, Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease, Aging (Albany NY), 4, 755, 10.18632/aging.100504 Kajkowski, 1997, Investigation of growth hormone releasing hormone receptor structure and activity using yeast expression technologies, Journal of Receptor and Signal Transduction Research, 17, 293, 10.3109/10799899709036610 Kanashiro-Takeuchi, 2015, New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor, Oncotarget, 6, 9728, 10.18632/oncotarget.3303 Kiaris, 2011, Growth hormone-releasing hormone: not only a neurohormone, Trends in Endocrinology and Metabolism, 22, 311, 10.1016/j.tem.2011.03.006 Kiaris, 2003, Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor, Proceedings of the National Academy of Sciences of the United States of America, 100, 9512, 10.1073/pnas.1533185100 Kiaris, 2002, Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs, Proceedings of the National Academy of Sciences of the United States of America, 99, 196, 10.1073/pnas.012590999 Körner, 2016, Specific biology of neuroendocrine tumors: Peptide receptors as molecular targets, Best Practice & Research. Clinical Endocrinology & Metabolism, 30, 19, 10.1016/j.beem.2016.01.001 Korner, 2009, Alternative splicing of pre-mRNA in cancer: Focus on G protein-coupled peptide hormone receptors, The American Journal of Pathology, 175, 461, 10.2353/ajpath.2009.081135 Kovari, 2014, Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor—Apocrine epithelium and carcinomas emerging as uniformly positive, APMIS, 122, 824, 10.1111/apm.12224 Liang, 2020, Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation, Proceedings of the National Academy of Sciences of the United States of America, 117, 6067, 10.1073/pnas.1904532117 Lin-Su, 2002, Growth hormone releasing hormone (GHRH) and the GHRH receptor, Reviews in Endocrine & Metabolic Disorders, 3, 313, 10.1023/A:1020949507265 Matsoukas, 2017, Dynamic properties of the growth hormone releasing hormone receptor (GHRHR) and molecular determinants of GHRH binding, Molecular BioSystems, 13, 1313, 10.1039/C7MB00130D Mayo, 1992, Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone, Molecular Endocrinology, 6, 1734 Mayo, 2003, International union of pharmacology. XXXV. The glucagon receptor family, Pharmacological Reviews, 55, 167, 10.1124/pr.55.1.6 Mayo, 1996, The growth-hormone-releasing hormone receptor: Signal transduction, gene expression, and physiological function in growth regulation, Annals of the New York Academy of Sciences, 805, 184, 10.1111/j.1749-6632.1996.tb17483.x Mezey, 2014, Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes, Journal of Cancer Research and Clinical Oncology, 140, 1641, 10.1007/s00432-014-1716-1 Peng, 2001, The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: Hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback, Endocrinology, 142, 1117, 10.1210/endo.142.3.8005 Rekasi, 2000, Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers, Proceedings of the National Academy of Sciences of the United States of America, 97, 10561, 10.1073/pnas.180313297 Ren, 2019, Growth hormone-releasing hormone receptor mediates cytokine production in ciliary and iris epithelial cells during LPS-induced ocular inflammation, Experimental Eye Research, 181, 277, 10.1016/j.exer.2019.02.021 Schally, 2001, Hypothalamic hormones and cancer, Frontiers in Neuroendocrinology, 22, 248, 10.1006/frne.2001.0217 Schally, 2012, Targeting to peptide receptors, 1219 Schally, 2008, Antagonists of growth-hormone-releasing hormone: An emerging new therapy for cancer, Nature Clinical Practice. Endocrinology & Metabolism, 4, 33, 10.1038/ncpendmet0677 Schulz, 2006, Immunocytochemical localisation of plasma membrane GHRH receptors in human tumors using a novel anti-peptide antibody, European Journal of Cancer, 42, 2390, 10.1016/j.ejca.2006.03.027 Szabo, 2022, Expression of growth hormone-releasing hormone and its receptor splice variants in primary human endometrial carcinomas: Novel therapeutic approaches, Molecules, 27, 10.3390/molecules27092671 Theophanous, 2009, The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer, Molecular Medicine, 15, 242, 10.2119/molmed.2008.00132 Veliçelebi, 1985, Specific binding of synthetic human pancreatic growth hormone releasing factor (1-40-OH) to bovine anterior pituitaries, Biochemical and Biophysical Research Communications, 126, 33, 10.1016/0006-291X(85)90567-4 Veyrat-Durebex, 2005, Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor, Journal of Cellular Physiology, 203, 335, 10.1002/jcp.20233 Villanova, 2019, Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma, Proceedings of the National Academy of Sciences of the United States of America, 116, 2226, 10.1073/pnas.1818865116 Xiong, 2020, Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target, Proceedings of the National Academy of Sciences of the United States of America, 117, 6726, 10.1073/pnas.1913433117 Zarandi, 2017, Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth, Peptides, 89, 60, 10.1016/j.peptides.2017.01.009 Zhang, 2015, Fgf8-deficient mice compensate for reduced GnRH neuronal population and exhibit normal testicular function, Frontiers in Endocrinology (Lausanne), 6, 151 Zhou, 2020, Structural basis for activation of the growth hormone-releasing hormone receptor, Nature Communications, 11, 5205, 10.1038/s41467-020-18945-0